Projects per year
Fingerprint
Dive into the research topics where Sharad A Ghamande is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 2 Similar Profiles
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects
-
-
MCG Minority-Based Community Clinical Oncology Program
Jillella, A., Ghamande, S. A., JILLELLA, A. P., JILLELLA, A. P., KALLAB, A., JILLELLA, A. P., KALLAB, A. M. & GHAMANDE, S.
Project: Research project
Research output
-
Standardization of lower extremity quantitative lymphedema measurements and associated patient-reported outcomes in gynecologic cancers
Russo, S., Walker, J. L., Carlson, J. W., Carter, J., Ward, L. C., Covens, A., Tanner, E. J., Armer, J. M., Ridner, S., Hayes, S., Taghian, A. G., Brunelle, C., Lopez-Acevedo, M., Davidson, B. A., Schaverien, M. V., Ghamande, S. A., Bernas, M., Cheville, A. L., Yost, K. J., Schmitz, K. & 7 others, , Feb 2021, In: Gynecologic Oncology. 160, 2, p. 625-632 8 p.Research output: Contribution to journal › Review article › peer-review
-
A 73-gene proliferative transcriptomic signature predicts uterine serous carcinoma patient survival and response to primary therapy
Tran, L. K. H., Tran, P. M. H., Mysona, D. P., Purohit, S. B., Myers, E., Lee, W. S., Dun, B., Xu, D., Liu, H., Hopkins, D., Nechtman, J., Scelsi, C. L., Mittal, P. K., Kleven, D., Wallbillich, J. J., Rungruang, B., Ghamande, S. & She, J. X., May 2020, In: Gynecologic Oncology. 157, 2, p. 340-347 8 p.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
A Randomized Phase II Trial of Epigenetic Priming with Guadecitabine and Carboplatin in Platinum-resistant, Recurrent Ovarian Cancer
Oza, A. M., Matulonis, U. A., Secord, A. A., Nemunaitis, J., Roman, L. D., Blagden, S. P., Banerjee, S., McGuire, W. P., Ghamande, S., Birrer, M. J., Fleming, G. F., Markham, M. J., Hirte, H. W., Provencher, D. M., Basu, B., Kristeleit, R., Armstrong, D. K., Schwartz, B., Braly, P., Hall, G. D. & 8 others, , Mar 1 2020, In: Clinical Cancer Research. 26, 5, p. 1009-1016 8 p.Research output: Contribution to journal › Article › peer-review
11 Scopus citations -
Are There Survival Differences Between Women with Equivalent Residual Disease After Interval Cytoreductive Surgery Compared with Primary Cytoreductive Surgery for Advanced Ovarian and Peritoneal Cancer?
Mysona, D. P., Ghamande, S., She, J. X., Tran, L., Tran, P., Rungruang, B. J., Chan, J. K., Bae-Jump, V. & Gehrig, P. A., 2020, (Accepted/In press) In: Annals of surgical oncology.Research output: Contribution to journal › Article › peer-review
-
Clinical calculator predictive of chemotherapy benefit in stage 1A uterine papillary serous cancers
Mysona, D. P., Tran, L. K. H., Tran, P. M. H., Gehrig, P. A., Van Le, L., Ghamande, S., Rungruang, B. J., Java, J., Mann, A. K., Liao, J., Kapp, D. S., Santos, B. D., She, J. X. & Chan, J. K., Jan 2020, In: Gynecologic Oncology. 156, 1, p. 77-84 8 p.Research output: Contribution to journal › Article › peer-review
2 Scopus citations